201 related articles for article (PubMed ID: 6777011)
41. 201Tl-labelled TlCl dosimetry revisited.
Castronovo FP
Nucl Med Commun; 1993 Feb; 14(2):104-7. PubMed ID: 8429986
[TBL] [Abstract][Full Text] [Related]
42. PET/CT-derived whole-body and bone marrow dosimetry of 89Zr-cetuximab.
Makris NE; Boellaard R; van Lingen A; Lammertsma AA; van Dongen GA; Verheul HM; Menke CW; Huisman MC
J Nucl Med; 2015 Feb; 56(2):249-54. PubMed ID: 25613538
[TBL] [Abstract][Full Text] [Related]
43. Kinetics and mobilization from the spleen of indium-111-labeled platelets during platelet apheresis.
Heyns AD; Badenhorst PN; Lötter MG; Pieters H; Wessels P
Transfusion; 1985; 25(3):215-8. PubMed ID: 4002306
[TBL] [Abstract][Full Text] [Related]
44. Kinetics, distribution and sites of destruction of 111indium-labelled human platelets.
Heyns AD; Lötter MG; Badenhorst PN; van Reenen OR; Pieters H; Minnaar PC; Retief FP
Br J Haematol; 1980 Feb; 44(2):269-80. PubMed ID: 6966503
[TBL] [Abstract][Full Text] [Related]
45. Gonad dose assessment in paediatric kidney nuclear medicine test using Monte Carlo simulation.
Lee DY; Kye YU; Kim HJ; Kim JK; Kang YR
J Radiat Res; 2020 Nov; 61(6):895-902. PubMed ID: 32930783
[TBL] [Abstract][Full Text] [Related]
46. Scintigraphic biodistribution and plasma kinetics of indium 111-labeled transferrin in dogs.
Berry CR; Fisher P; Koblik PD; Guilford WG; Hornof WH
Am J Vet Res; 1997 Nov; 58(11):1188-92. PubMed ID: 9361875
[TBL] [Abstract][Full Text] [Related]
47. [Scintigraphic studies of gonadal burden in radiosynoviortheses of the knee joint with yttrium 90].
Wagener P; Münch H; Junker D
Z Rheumatol; 1988; 47(4):201-4. PubMed ID: 3188677
[TBL] [Abstract][Full Text] [Related]
48. Kinetics, distribution, and sites of destruction of canine blood platelets with In-111 oxine.
Lötter MG; Badenhorst PN; Heyns AD; Van Reenen OR; Pieters H; Minnaar PC
J Nucl Med; 1980 Jan; 21(1):36-40. PubMed ID: 6766182
[TBL] [Abstract][Full Text] [Related]
49. Monoclonal antibody BW431/26 labelled with technetium 99m and indium 111: an investigation of the biodistribution and the dosimetry in patients.
Benz P; Oberhausen E; Berberich R
Eur J Nucl Med; 1991; 18(10):813-6. PubMed ID: 1743204
[TBL] [Abstract][Full Text] [Related]
50. Pharmacokinetics and normal organ dosimetry following intraperitoneal rhenium-186-labeled monoclonal antibody.
Breitz HB; Durham JS; Fisher DR; Weiden PL; DeNardo GL; Goodgold HM; Nelp WB
J Nucl Med; 1995 May; 36(5):754-61. PubMed ID: 7738644
[TBL] [Abstract][Full Text] [Related]
51. Radiation dosimetry for indium-111-pentetreotide.
Stabin MG; Kooij PP; Bakker WH; Inoue T; Endo K; Coveney J; de Jong R; Minegishi A
J Nucl Med; 1997 Dec; 38(12):1919-22. PubMed ID: 9430470
[TBL] [Abstract][Full Text] [Related]
52. Patient-specific dosimetry of pretargeted radioimmunotherapy using CC49 fusion protein in patients with gastrointestinal malignancies.
Shen S; Forero A; LoBuglio AF; Breitz H; Khazaeli MB; Fisher DR; Wang W; Meredith RF
J Nucl Med; 2005 Apr; 46(4):642-51. PubMed ID: 15809487
[TBL] [Abstract][Full Text] [Related]
53. Dosimetry of iodine-123-epidepride: a dopamine D2 receptor ligand.
Votaw JR; Ansari MS; Mason NS; Schmidt D; de Paulis T; Holburn G; Clanton JA; Votaw DB; Manning RG; Kessler RM
J Nucl Med; 1995 Jul; 36(7):1316-21. PubMed ID: 7790962
[TBL] [Abstract][Full Text] [Related]
54. Radionuclide hysterosalpingography with technetium-99m-pertechnetate: application and radiation dose to the ovaries.
Yang KT; Chiang JH; Chen BS; Liang CH; Lee SF; Liao SC
J Nucl Med; 1992 Feb; 33(2):282-6. PubMed ID: 1310106
[TBL] [Abstract][Full Text] [Related]
55. Determination of human absorbed dose of 67GA-DTPA-ACTH based on distribution data in rats.
Shanehsazzadeh S; Jalilian AR; Sadeghi HR; Allahverdi M
Radiat Prot Dosimetry; 2009 Jun; 134(2):79-86. PubMed ID: 19470447
[TBL] [Abstract][Full Text] [Related]
56. Assessment of human biodistribution and dosimetry of 4-fluoro-11beta-methoxy-16alpha-18F-fluoroestradiol using serial whole-body PET/CT.
Beauregard JM; Croteau E; Ahmed N; van Lier JE; Bénard F
J Nucl Med; 2009 Jan; 50(1):100-7. PubMed ID: 19091905
[TBL] [Abstract][Full Text] [Related]
57. 111In-tropolonate labelled platelets; studies in normals and in patients with thrombocytopenia.
Louwes H; Beekhuis H; Goedemans WT; Keijser SP; Schuurman JJ
Eur J Nucl Med; 1987; 13(1):47-51. PubMed ID: 3109918
[TBL] [Abstract][Full Text] [Related]
58. Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.
Kemerink GJ; Liu X; Kieffer D; Ceyssens S; Mortelmans L; Verbruggen AM; Steinmetz ND; Vanderheyden JL; Green AM; Verbeke K
J Nucl Med; 2003 Jun; 44(6):947-52. PubMed ID: 12791824
[TBL] [Abstract][Full Text] [Related]
59. Kinetics and sites of sequestration of indium 111-labeled human platelets during cardiopulmonary bypass.
Hope AF; Heyns AD; Lötter MG; van Reenen OR; de Kock F; Badenhorst PN; Pieters H; Kotze H; Meyer JM; Minnaar PC
J Thorac Cardiovasc Surg; 1981 Jun; 81(6):880-6. PubMed ID: 6971967
[TBL] [Abstract][Full Text] [Related]
60. Double-tracer dosimetry of organs in assessment of bone marrow involvement by two monoclonal antibodies.
Korppi-Tommola ET; Kairemo KJ; Jekunen AP; Niskanen EO; Savolainen SE
Acta Oncol; 1996; 35(3):357-65. PubMed ID: 8679267
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
